Ariad Investor Says Drug Side Effects Led To Stock Drop

Ariad Investor Says Drug Side Effects Led To Stock Drop

An investor hit Ariad Pharmaceuticals Inc. with a putative class action in Massachusetts federal court on Thursday, alleging the oncology company made false statements about its leukemia drug Iclusig then disclosed the dangerous side effects later, causing ...read more

  • Tags: